Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy
- PMID: 37599145
- DOI: 10.1016/j.jelectrocard.2023.07.002
Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy
Abstract
Introduction: A 12‑lead electrocardiography (ECG)-based convolutional neural network (CNN) model can detect hypertrophic cardiomyopathy (HCM). However, since these models do not rely on discrete measurements as inputs, it is not apparent what drives their performance. We hypothesized that saliency maps could be used to visually identify ECG segments that contribute to a CNN's robust classification of HCM.
Methods: We derived a new one‑lead (lead I) CNN model based on median beats using the same methodology and cohort used for the original 12‑lead CNN model (3047 patients with HCM, and 63,926 sex- and age-matched non-HCM controls). One‑lead, median-beat saliency maps were generated and visually evaluated in an independent cohort of 100 patients with a diagnosis of HCM and a high artificial intelligence (AI)-ECG-HCM probability score to determine which ECG segments contributed to the model's detection of HCM.
Results: The one‑lead, median-beat CNN had an AUC of 0.90 (95% CI 0.89-0.92) for HCM detection, similar to the original 12‑lead ECG model. In the independent HCM cohort (n = 100), saliency maps highlighted the ST-T segment in 92 ECGs, the atrial depolarization segment in 12 ECGs, and the QRS complex in 5 ECGs.
Conclusions: Saliency maps of a one‑lead, median-beat-based CNN model identified perturbations in ventricular repolarization as the main region of interest in detecting HCM.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Mayo Clinic, along with Konstantinos Siontis, Michael Ackerman, Zachi Attia, Paul Friedman, and Peter Noseworthy have intellectual property related to detecting hypertrophic cardiomyopathy with AI-ECG. This algorithm has been licensed to Anumana, Inc. The other authors have nothing to declare. M.M. was supported by grants from the Swedish Heart Lung Foundation, Erik and Edith Fernström Foundation for Medical Research, Svensk Förening för Klinisk Fysiologi, and Karolinska Institutet.
Comment in
-
Explainable-by-design: Challenges, pitfalls, and opportunities for the clinical adoption of AI-enabled ECG.J Electrocardiol. 2023 Nov-Dec;81:292-294. doi: 10.1016/j.jelectrocard.2023.08.006. Epub 2023 Aug 15. J Electrocardiol. 2023. PMID: 37635030 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
